Skip to main content
NVDA+0.12%AAPL-0.11%GOOGL-0.39%MSFT+0.70%AMZN-0.59%TSM+1.56%SPCX+1.84%META-0.61%AVGO+0.82%TSLA-0.44%LLY-1.87%BRK-B-0.44%MU+3.59%SKHY+4.69%WMT-0.84%JPM-1.27%AMD+2.41%V-1.39%XOM+2.85%JNJ-1.58%ASMLa-1.08%MA-1.98%ABBV+0.18%CVX+2.82%INTC+2.33%0700.HK+0.94%COST-1.01%1398.HK-1.50%CSCO+1.82%KO-2.14%ORCL+1.43%UNH-0.25%PG-2.65%BAC-0.54%1816.HK+0.44%3988.HK-0.50%HD-2.83%CAT-1.95%0005.HK-1.04%PM-0.41%HSBA.L-1.40%AP2d-0.07%0857.HK-0.93%0939.HK+0.51%AMAT+1.85%GE-2.41%1288.HK-1.94%NVS-3.26%DELL+2.53%LRCX+1.10%EURAUD-1.63%EURCAD-1.41%AUDCHF+1.39%AUDUSD+1.26%EURNZD-1.24%CADCHF+1.17%EURJPY-1.04%USDCAD-1.03%NZDCHF+1.01%USDTHB+0.96%GBPAUD-0.92%NZDUSD+0.88%CHFJPY-0.84%USDPLN+0.72%GBPCAD-0.71%EURGBP-0.71%USDJPY-0.70%CHFNOK-0.67%PLNJPY-0.62%USDZAR+0.61%AUDJPY+0.61%GBPNZD-0.56%EURPLN+0.55%CHFSGD-0.48%GBPCHF+0.45%EURZAR+0.45%USDTRY+0.43%NZDSGD+0.42%GBPZAR+0.41%GBPTRY+0.41%AUDNZD+0.39%CHFSEK-0.39%EURUSD-0.37%AUDDKK+0.36%CADJPY+0.36%GBPJPY-0.36%GBPUSD+0.33%GBPHKD+0.32%USDMXN-0.31%GBPMXN-0.28%AUDSGD+0.28%EURCZK+0.28%EURNOK-0.28%EURCHF-0.24%USDCNH-0.24%AUDCAD+0.23%EURCNH-0.21%NOKJPY+0.19%NZDJPY+0.18%USDSEK+0.18%USDILS+0.16%USDDKK+0.16%NZDCAD-0.15%USDCHF+0.12%GBPSGD-0.11%USDNOK-0.11%EURHKD-0.10%EURSGD-0.09%AUDNOK+0.08%USDSGD+0.08%USDHKD-0.07%USDCOP-0.04%NZDMXN+0.02%SGDJPY+0.01%EURDKK-0.01%EURSEK+0.01%USOIL+3.79%UKOIL+3.23%XNGUSD-2.96%HG1+1.91%COCOA-0.90%XAGUSD-0.75%GAGUSD-0.73%C1-0.66%COFFEE-0.63%XAUUSD-0.53%GAUUSD-0.52%SUGAR+0.45%BTCUSD+0.28%ETHUSD+20.55%USDTUSD+0.02%XRPUSD+14.70%SOLUSD+14.32%TRXUSDT+0.50%ZECUSDT+1.35%DOGEUSD+19.00%XMRUSDT+0.96%LINKUSD+19.73%XLMUSD+0.76%BCHUSDT+4.29%UNIUSD+1.85%LTCUSD+13.73%SUIUSD+1.89%HBARUSDT-1.11%TONUSD+30.40%TAOUSDT+1.07%AAVEUSD+0.38%DOTUSDT+1.17%ICPUSDT+2.43%WLDUSDT-4.07%ONDOUSDT+0.47%ARBUSDT+0.19%JUPUSDT-0.30%ATOMUSDT+4.56%INJUSDT-0.87%STXUSDT-1.37%TIAUSDT-2.10%FETUSDT+1.19%PYTHUSDT+0.01%SEIUSDT+0.84%IMXUSDT+2.21%GRTUSDT+0.91%OPUSDT-0.11%WIFUSDT+1.37%IOTAUSDT-0.05%AXSUSDT+1.92%POLUSDT+1.50%FARTCOINUSDT+0.84%EOSUSDT-1.48%DYDXUSDT+2.02%GALAUSDT+1.41%ORDIUSDT+2.35%RONINUSDT+0.24%NOTUSDT+3.13%NVDA+0.12%AAPL-0.11%GOOGL-0.39%MSFT+0.70%AMZN-0.59%TSM+1.56%SPCX+1.84%META-0.61%AVGO+0.82%TSLA-0.44%LLY-1.87%BRK-B-0.44%MU+3.59%SKHY+4.69%WMT-0.84%JPM-1.27%AMD+2.41%V-1.39%XOM+2.85%JNJ-1.58%ASMLa-1.08%MA-1.98%ABBV+0.18%CVX+2.82%INTC+2.33%0700.HK+0.94%COST-1.01%1398.HK-1.50%CSCO+1.82%KO-2.14%ORCL+1.43%UNH-0.25%PG-2.65%BAC-0.54%1816.HK+0.44%3988.HK-0.50%HD-2.83%CAT-1.95%0005.HK-1.04%PM-0.41%HSBA.L-1.40%AP2d-0.07%0857.HK-0.93%0939.HK+0.51%AMAT+1.85%GE-2.41%1288.HK-1.94%NVS-3.26%DELL+2.53%LRCX+1.10%EURAUD-1.63%EURCAD-1.41%AUDCHF+1.39%AUDUSD+1.26%EURNZD-1.24%CADCHF+1.17%EURJPY-1.04%USDCAD-1.03%NZDCHF+1.01%USDTHB+0.96%GBPAUD-0.92%NZDUSD+0.88%CHFJPY-0.84%USDPLN+0.72%GBPCAD-0.71%EURGBP-0.71%USDJPY-0.70%CHFNOK-0.67%PLNJPY-0.62%USDZAR+0.61%AUDJPY+0.61%GBPNZD-0.56%EURPLN+0.55%CHFSGD-0.48%GBPCHF+0.45%EURZAR+0.45%USDTRY+0.43%NZDSGD+0.42%GBPZAR+0.41%GBPTRY+0.41%AUDNZD+0.39%CHFSEK-0.39%EURUSD-0.37%AUDDKK+0.36%CADJPY+0.36%GBPJPY-0.36%GBPUSD+0.33%GBPHKD+0.32%USDMXN-0.31%GBPMXN-0.28%AUDSGD+0.28%EURCZK+0.28%EURNOK-0.28%EURCHF-0.24%USDCNH-0.24%AUDCAD+0.23%EURCNH-0.21%NOKJPY+0.19%NZDJPY+0.18%USDSEK+0.18%USDILS+0.16%USDDKK+0.16%NZDCAD-0.15%USDCHF+0.12%GBPSGD-0.11%USDNOK-0.11%EURHKD-0.10%EURSGD-0.09%AUDNOK+0.08%USDSGD+0.08%USDHKD-0.07%USDCOP-0.04%NZDMXN+0.02%SGDJPY+0.01%EURDKK-0.01%EURSEK+0.01%USOIL+3.79%UKOIL+3.23%XNGUSD-2.96%HG1+1.91%COCOA-0.90%XAGUSD-0.75%GAGUSD-0.73%C1-0.66%COFFEE-0.63%XAUUSD-0.53%GAUUSD-0.52%SUGAR+0.45%BTCUSD+0.28%ETHUSD+20.55%USDTUSD+0.02%XRPUSD+14.70%SOLUSD+14.32%TRXUSDT+0.50%ZECUSDT+1.35%DOGEUSD+19.00%XMRUSDT+0.96%LINKUSD+19.73%XLMUSD+0.76%BCHUSDT+4.29%UNIUSD+1.85%LTCUSD+13.73%SUIUSD+1.89%HBARUSDT-1.11%TONUSD+30.40%TAOUSDT+1.07%AAVEUSD+0.38%DOTUSDT+1.17%ICPUSDT+2.43%WLDUSDT-4.07%ONDOUSDT+0.47%ARBUSDT+0.19%JUPUSDT-0.30%ATOMUSDT+4.56%INJUSDT-0.87%STXUSDT-1.37%TIAUSDT-2.10%FETUSDT+1.19%PYTHUSDT+0.01%SEIUSDT+0.84%IMXUSDT+2.21%GRTUSDT+0.91%OPUSDT-0.11%WIFUSDT+1.37%IOTAUSDT-0.05%AXSUSDT+1.92%POLUSDT+1.50%FARTCOINUSDT+0.84%EOSUSDT-1.48%DYDXUSDT+2.02%GALAUSDT+1.41%ORDIUSDT+2.35%RONINUSDT+0.24%NOTUSDT+3.13%
NT

Nurix Therapeutics, Inc. (NRIX)

NASDAQ • Healthcare

$25.51
-$0.5 (-2.0%)
Market open

Last close at October 22, 2026 at 20:00 UTC

Open$25.86
Previous Close$25.51
Day Range$25.18 - $26.23
Avg. Volume (3M)2.4M
Market Cap$2.7B
P/E Ratio10.2
52 Week Range
$10.38$28.23

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$673M100%
Gross Profitminus cost of goods$670.9M100%
Operating Incomeminus R&D and overhead$559.4M83%
Net Incomeminus taxes and the rest$549.8M82%

In plain terms: out of every $100 in revenue, Nurix Therapeutics, Inc. keeps $82 as net profit.

Fundamentals & Financials

Revenue (TTM)
$701.9M
Net Income (TTM)
$294.8M
EPS (TTM)
$2.51
ROA (TTM)
24.67%
Current Ratio
8.44

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-3.9%Q2 2026-$0.79
-12.1%Q3 2026-$0.81
+887.1%Q4 2026$4.73

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +887.1%

Nurix Therapeutics’ most recent results for the third fiscal quarter of 2026, reported October 12, 2026, included operating cash flow of about $615.6 million as the company continued advancing its oncology and immunology pipeline across programs such as NX-5948, NX-2127, and NX-1607. Consensus for the next period calls for EPS of -$0.50 on revenue of $31.6 million.

View full earnings history

About Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc. develops cancer and immunology medicines as a biotechnology company listed on NASDAQ under NRIX, centered on discovering, developing, and commercializing small molecule therapies and antibody therapies for cancer, inflammatory conditions, and other diseases. The business generated $84.0 million of revenue in FY2025.

Name
Nurix Therapeutics, Inc.
CEO
Arthur T. Sands
Website
www.nurixtx.com
Industry
Healthcare
Year Founded
2009
Employees
317

Today's Snapshot

AI-generated

NRIX opened 1.4% lower at 25.15, in line with a weaker sector.

Trading Volume

Below 10d avg (3.2M)

235K

vs S&P 500 Today

Underperforming Market

-1.50%

Updated: October 23, 2026 at 14:44 UTC

Technical Indicators

6 Buy1 Neutral1 Sell
NRIX exhibits broad bullish alignment as price is above its short- and long-term moving averages and momentum readings are positive, with MACD also supportive; the ADX shows a moderate trending environment rather than an extreme. Some oscillators are extended, and on-balance volume is not confirming the move, but volatility is moderate and the classic pivot is nearby, offering a reference. Overall the weight of moving averages and momentum favors the upside. Technical takeaway: Strong Buy.
All signals
  • EMA (5 indicators)$20.59 - $24.78
    Buy
  • RSI (14)56.47
    Neutral
  • Stochastic %K (14, 3, 3)85.01
    Sell
  • MACD Level (12, 26)0.26
    Buy

Peers & Related Assets

RVMDRevolution Medicines, Inc.
$187.69-3.4%
KYMRKymera Therapeutics, Inc.
$110.85-1.6%
TNGXTango Therapeutics, Inc.
$27.93+3.5%
SNDXSyndax Pharmaceuticals, Inc.
$13.57+3.2%
RIGLRigel Pharmaceuticals, Inc.
$48.86-0.0%
KURAKura Oncology, Inc.
$9.86-0.2%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.